title: Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France. pierre.peterlin@chu-nantes.fr.
authors.forename: Pierre
authors.initials: P
authors.lastname: Peterlin
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Alice
authors.initials: A
authors.lastname: Garnier
authors.affiliation: Service de Pneumologie et de Transplantation Thoracique, Centre Hospitalier et Universitaire (CHU) de Nantes, Nantes, France.
authors.forename: Adrien
authors.initials: A
authors.lastname: Tissot
authors.affiliation: Service de Néphrologie-Immunologie Clinique, Centre Hospitalier et Universitaire (CHU) de Nantes, Nantes, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Garandeau
authors.affiliation: Service de Pneumologie et de Transplantation Thoracique, Centre Hospitalier et Universitaire (CHU) de Nantes, Nantes, France.
authors.forename: Delphine
authors.initials: D
authors.lastname: Houreau-Langlard
authors.affiliation: Service de Néphrologie-Immunologie Clinique, Centre Hospitalier et Universitaire (CHU) de Nantes, Nantes, France.
authors.forename: Maryvonne
authors.initials: M
authors.lastname: Hourmant
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Vantyghem
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Antoine
authors.initials: A
authors.lastname: Bonnet
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Guillaume
authors.affiliation: Service d'Hématologie Biologique, Centre Hospitalier et Universitaire (CHU), Nantes, France.
authors.forename: Marie C
authors.initials: MC
authors.lastname: Béné
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Steven
authors.initials: S
authors.lastname: Le Gouill
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Moreau
authors.affiliation: Service d'Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Centre Hospitalier et Universitaire (CHU) de Nantes, CHU Hotel-Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
authors.forename: Patrice
authors.initials: P
authors.lastname: Chevallier
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000209:etiology; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000209:etiology; D010087:Oxides / Q000008:administration & dosage; D011183:Postoperative Complications / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000209:etiology; D014212:Tretinoin / Q000008:administration & dosage
chemical_list: D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide